mozambique
Medicines for Malaria Venture
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 2
Supporting development of a key easy-to-administer and long-protective antimalarial - dihydroartemisinin-piperaquine (Euroartesim).
SolidarMed
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 2
Saving children's lives with colors: improve pediatric case management at emergency rooms.
Project 3
Maternal Health Project (MAMA): improve maternal and neonatal health care, increase demand and supply of services.
Project 4
Institutional support to Wiwanana (Community Action for Health Foundation in Mozambique): support national foundation in administrative and financial management to become sustainable.
Countries
Impact
730,000 persons
Duration
2005 - ongoing
Activity
Administrative & Financial Support
Project 5
Emergency transport through establishment of a local company.
Swiss Tropical and Public Health Institute
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 2
RTS,S: most advanced candidate for a malaria vaccine. Swiss TPH helped coordinate a large-scale clinical trail involving more than 16,000 children. Swiss TPH also calculated the long-term impact and cost-effectiveness of RTS,S in 43 African countries.
Countries
burkina-faso gabon ghana kenya malawi mozambique tanzania
Impact
16,000 children
Duration
2009 - 2014
Activity
Innovation & Research
Syngenta
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 1
Launch of ACTELLIC 300CS for IRS & following establishment of NgenIRS project. The project's aim is to make the most effective, long lasting insecticides available to malaria control programmes to support insecticide resistance management strategies.
Countries
benin burkina-faso ethiopia ghana kenya madagascar mali malawi mozambique rwanda tanzania uganda zambia zimbabwe
Impact
6.7 million units of ACTELLIC procured
Duration
2013/2016 - ongoing
Activity
Vector control